Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms

被引:344
作者
Stehouwer, Coen D. A.
Smulders, Yvo M.
机构
[1] Maastricht Univ, Dept Med, Div Gen Internal Med, NL-6202 AZ Maastricht, Netherlands
[2] Univ Hosp Maastricht, Maastricht, Netherlands
[3] Vrye Univ, Univ Med Ctr, Dept Internal Med, Amsterdam, Netherlands
[4] Vrye Univ, Univ Med Ctr, Cardiovasc Res Inst, Amsterdam, Netherlands
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 08期
关键词
D O I
10.1681/ASN.2005121288
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Microalbuminuria is a strong and independent indicator of increased cardiovascular risk among individuals with and without diabetes. Therefore, microalbuminuria can be used for stratification of risk for cardiovascular disease. Once microalbuminuria is present, cardiovascular risk factor reduction should be more "aggressive." The nature of the link between microalbuminuria and cardiovascular risk, however, remains poorly understood. There is no strong evidence that microalbuminuria causes atherothrombosis or that atherothrombosis causes microalbuminuria. Many studies have tested the hypothesis that a common risk factor underlies the association between microalbuminuria and cardiovascular disease but, again, have found no strong evidence in favor of this contention. At present, the most likely possibility is that a common pathophysiologic process, such as endothelial dysfunction, chronic low-grade inflammation, or increased transvascular leakage of macromolecules, underlies the association between microalbuminuria and cardiovascular disease, but more and prospective studies of these hypotheses are needed.
引用
收藏
页码:2106 / 2111
页数:6
相关论文
共 37 条
[1]   Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study [J].
Ärnlöv, J ;
Evans, JC ;
Meigs, JB ;
Wang, TJ ;
Fox, CS ;
Levy, D ;
Benjamin, EJ ;
D'Agostino, RB ;
Vasan, RS .
CIRCULATION, 2005, 112 (07) :969-975
[2]  
CAO JJ, 2005, ATHEROSCLEROSIS 1019
[3]   PROGNOSTIC VALUE OF URINARY ALBUMIN EXCRETION RATE AND OTHER RISK-FACTORS IN ELDERLY DIABETIC-PATIENTS AND NONDIABETIC CONTROL SUBJECTS SURVIVING THE 1ST 5 YEARS AFTER ASSESSMENT [J].
DAMSGAARD, EM ;
FROLAND, A ;
JORGENSEN, OD ;
MOGENSEN, CE .
DIABETOLOGIA, 1993, 36 (10) :1030-1036
[4]   Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, ME ;
Mitch, WE ;
Brenner, BM .
CIRCULATION, 2004, 110 (08) :921-927
[5]   Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, MF ;
Mitch, WE ;
Brenner, BM .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320
[6]   ALBUMINURIA REFLECTS WIDESPREAD VASCULAR DAMAGE - THE STENO HYPOTHESIS [J].
DECKERT, T ;
FELDTRASMUSSEN, B ;
BORCHJOHNSEN, K ;
JENSEN, T ;
KOFOEDENEVOLDSEN, A .
DIABETOLOGIA, 1989, 32 (04) :219-226
[7]   What determines glomerular capillary permeability? [J].
Deen, WM .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (10) :1412-1414
[8]   The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus - A systematic overview of the literature [J].
Dinneen, SF ;
Gerstein, HC .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (13) :1413-1418
[9]   Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].
Gerstein, HC ;
Mann, JFE ;
Yi, QL ;
Zinman, B ;
Dinneen, SF ;
Hoogwerf, B ;
Hallé, JP ;
Young, J ;
Rashkow, A ;
Joyce, C ;
Nawaz, S ;
Yusuf, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426
[10]   Why do we not all have proteinuria?: An update of our current understanding of the glomerular barrier [J].
Haraldsson, B ;
Sörensson, J .
NEWS IN PHYSIOLOGICAL SCIENCES, 2004, 19 :7-10